Helen Pentikis
Founder at Zero Point Five Therapeutics, Inc.
Helen Pentikis active positions
| Companies | Position | Start | End |
|---|---|---|---|
Symbiomix Therapeutics LLC
 Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | Chief Tech/Sci/R&D Officer | - | - |
SAJE Pharma LLC
 SAJE Pharma LLC Pharmaceuticals: MajorHealth Technology SAJE Pharma LLC operates as a biopharmaceutical company. It focuses on developing new therapeutic agents that provide significant benefits over available therapies for rare and common diseases with unmet medical needs. The company was founded by Matthews O. Bradley and Helen S. Pentikis in 2011 and is headquartered in Baltimore, MD. | Chief Executive Officer | 31/12/2010 | - |
| Chief Tech/Sci/R&D Officer | 31/12/2010 | - | |
| Founder | 31/12/2010 | - | |
Zero Point Five Therapeutics, Inc.
 Zero Point Five Therapeutics, Inc. BiotechnologyHealth Technology Zero Point Five Therapeutics, Inc. is a drug development company that focuses on neglected tropical diseases and soil-transmitted helminthiasis. The company is based in Baltimore, MD. The company was founded by Helen S. Pentikis, Joseph L. Amprey. Joseph L. Amprey has been the CEO since incorporation. | Chief Tech/Sci/R&D Officer | - | - |
| Founder | - | - |
Career history of Helen Pentikis
Former positions of Helen Pentikis
| Companies | Position | Start | End |
|---|---|---|---|
| PROCESSA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - | - |
Training of Helen Pentikis
| Wake Forest University | Undergraduate Degree |
| University of Maryland | Doctorate Degree |
Statistics
International
| United States | 7 |
Operational
| Chief Tech/Sci/R&D Officer | 5 |
| Founder | 3 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| PROCESSA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
SAJE Pharma LLC
SAJE Pharma LLC Pharmaceuticals: MajorHealth Technology SAJE Pharma LLC operates as a biopharmaceutical company. It focuses on developing new therapeutic agents that provide significant benefits over available therapies for rare and common diseases with unmet medical needs. The company was founded by Matthews O. Bradley and Helen S. Pentikis in 2011 and is headquartered in Baltimore, MD. | Health Technology |
Symbiomix Therapeutics LLC
Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | Health Technology |
Zero Point Five Therapeutics, Inc.
Zero Point Five Therapeutics, Inc. BiotechnologyHealth Technology Zero Point Five Therapeutics, Inc. is a drug development company that focuses on neglected tropical diseases and soil-transmitted helminthiasis. The company is based in Baltimore, MD. The company was founded by Helen S. Pentikis, Joseph L. Amprey. Joseph L. Amprey has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Helen Pentikis
- Experience